CORRECTION OF INTERFERON-α-INDUCED DENDRITIC CELL DYSFUNCTIONS IN IMMUNOCOMPROMISED PATIENTS
The correction of impaired functions of in vitro generated interferon-alpha-induced dendritic cells (IFN-DCs) in patients with malignant brain tumors (n = 8), malignant lymphomas (n = 14) and pulmonary tuberculosis (n = 26) was analyzed in the present study. The principal possibility of restoring re...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Scientific Сentre for Family Health and Human Reproduction Problems
2012-05-01
|
| Series: | Acta Biomedica Scientifica |
| Subjects: | |
| Online Access: | https://www.actabiomedica.ru/jour/article/view/896 |
| _version_ | 1797237677218594816 |
|---|---|
| author | O. Yu. Leplina L. V. Sakhno A. A. Ostanin S. S. Bogachev E. R. Chernykh |
| author_facet | O. Yu. Leplina L. V. Sakhno A. A. Ostanin S. S. Bogachev E. R. Chernykh |
| author_sort | O. Yu. Leplina |
| collection | DOAJ |
| description | The correction of impaired functions of in vitro generated interferon-alpha-induced dendritic cells (IFN-DCs) in patients with malignant brain tumors (n = 8), malignant lymphomas (n = 14) and pulmonary tuberculosis (n = 26) was analyzed in the present study. The principal possibility of restoring reduced functional activity of patient DCs was shown. The addition of recombinant human IL-2, complex of pro-inflammatory cytokines, double-stranded human DNA or polyoxidonium to IFN-DC cultures at the stage of maturation could significantly increase the allostimulatory activity of DCs in patients with malignant lymphomas and pulmonary tuberculosis, as well as enhance the cytotoxic activity of cancer patient DCs against NK- and TRAIL-resistant tumor cell line HEp-2. These findings offer new approaches to the correction of DC dysfunctions in the pathology and justify ways of improving the treatment of infectious diseases and cancer using dendritic cell vaccines. |
| first_indexed | 2024-03-08T12:22:56Z |
| format | Article |
| id | doaj.art-3f78891c3b9b421d8fda264799976e3c |
| institution | Directory Open Access Journal |
| issn | 2541-9420 2587-9596 |
| language | Russian |
| last_indexed | 2024-04-24T17:23:33Z |
| publishDate | 2012-05-01 |
| publisher | Scientific Сentre for Family Health and Human Reproduction Problems |
| record_format | Article |
| series | Acta Biomedica Scientifica |
| spelling | doaj.art-3f78891c3b9b421d8fda264799976e3c2024-03-28T07:49:04ZrusScientific Сentre for Family Health and Human Reproduction ProblemsActa Biomedica Scientifica2541-94202587-95962012-05-0103(2)104108842CORRECTION OF INTERFERON-α-INDUCED DENDRITIC CELL DYSFUNCTIONS IN IMMUNOCOMPROMISED PATIENTSO. Yu. Leplina0L. V. Sakhno1A. A. Ostanin2S. S. Bogachev3E. R. Chernykh4Institute of Clinical Immunology SB RAMSInstitute of Clinical Immunology SB RAMSInstitute of Clinical Immunology SB RAMSInstitute of cytology and genetics SB RAMSInstitute of Clinical Immunology SB RAMSThe correction of impaired functions of in vitro generated interferon-alpha-induced dendritic cells (IFN-DCs) in patients with malignant brain tumors (n = 8), malignant lymphomas (n = 14) and pulmonary tuberculosis (n = 26) was analyzed in the present study. The principal possibility of restoring reduced functional activity of patient DCs was shown. The addition of recombinant human IL-2, complex of pro-inflammatory cytokines, double-stranded human DNA or polyoxidonium to IFN-DC cultures at the stage of maturation could significantly increase the allostimulatory activity of DCs in patients with malignant lymphomas and pulmonary tuberculosis, as well as enhance the cytotoxic activity of cancer patient DCs against NK- and TRAIL-resistant tumor cell line HEp-2. These findings offer new approaches to the correction of DC dysfunctions in the pathology and justify ways of improving the treatment of infectious diseases and cancer using dendritic cell vaccines.https://www.actabiomedica.ru/jour/article/view/896dendritic cellsinterferon-alphacorrectioncytotoxicityallostimulatory activity |
| spellingShingle | O. Yu. Leplina L. V. Sakhno A. A. Ostanin S. S. Bogachev E. R. Chernykh CORRECTION OF INTERFERON-α-INDUCED DENDRITIC CELL DYSFUNCTIONS IN IMMUNOCOMPROMISED PATIENTS Acta Biomedica Scientifica dendritic cells interferon-alpha correction cytotoxicity allostimulatory activity |
| title | CORRECTION OF INTERFERON-α-INDUCED DENDRITIC CELL DYSFUNCTIONS IN IMMUNOCOMPROMISED PATIENTS |
| title_full | CORRECTION OF INTERFERON-α-INDUCED DENDRITIC CELL DYSFUNCTIONS IN IMMUNOCOMPROMISED PATIENTS |
| title_fullStr | CORRECTION OF INTERFERON-α-INDUCED DENDRITIC CELL DYSFUNCTIONS IN IMMUNOCOMPROMISED PATIENTS |
| title_full_unstemmed | CORRECTION OF INTERFERON-α-INDUCED DENDRITIC CELL DYSFUNCTIONS IN IMMUNOCOMPROMISED PATIENTS |
| title_short | CORRECTION OF INTERFERON-α-INDUCED DENDRITIC CELL DYSFUNCTIONS IN IMMUNOCOMPROMISED PATIENTS |
| title_sort | correction of interferon α induced dendritic cell dysfunctions in immunocompromised patients |
| topic | dendritic cells interferon-alpha correction cytotoxicity allostimulatory activity |
| url | https://www.actabiomedica.ru/jour/article/view/896 |
| work_keys_str_mv | AT oyuleplina correctionofinterferonainduceddendriticcelldysfunctionsinimmunocompromisedpatients AT lvsakhno correctionofinterferonainduceddendriticcelldysfunctionsinimmunocompromisedpatients AT aaostanin correctionofinterferonainduceddendriticcelldysfunctionsinimmunocompromisedpatients AT ssbogachev correctionofinterferonainduceddendriticcelldysfunctionsinimmunocompromisedpatients AT erchernykh correctionofinterferonainduceddendriticcelldysfunctionsinimmunocompromisedpatients |